Nuwellis Inc Revenue per Employee (NUWE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Nuwellis Inc   (NASDAQ: NUWE)
 

Nuwellis Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 14.14% in the second quarter 2026, year on year to cumulative value of $9 million, Nuwellis Inc 's revenue per employee grew on a trailing twelve months basis to $ 237,184, this marks a new company high.
Within the Healthcare sector Employees of 369 other companies have achieved higher revenue per employee. While Nuwellis Inc 's total ranking has deteriorated compared to the previous quarter from 2545 to 2855. Nuwellis Inc has 38 employees.


What is Sales per Employee Ratio?







NUWE Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 14.14 % 26.21 % 8.02 % -6.34 % -21.38 %
Sales per Employee (TTM) $ 237,184 230,763 217,632 212,895 216,842
NUWE's Total Ranking # 2855 # 2545 # 2499 # 2356 #
Seq. Revenue Change -18.06 % -0.87 % 9.34 % 28.52 % -9.4 %


Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 370
Overall Market # 2855

Revenue per Employee Statistics
High Average Low
$ 237,184 $ 182,797 $ 80,368
(Jun 30 2026)   (Jun 30 2017)



Financial Statements
Nuwellis Inc 's Revenue MRQ $ 2 Millions Visit NUWE's Income Statement
Nuwellis Inc 's Revenues TTM $ 9 Millions Visit NUWE's aggregate revenue growth
What are NUWE's Sales? Visit NUWE's Sales by Segment


  News about Nuwellis Inc Revenue per employee

Nuwellis, Inc. Navigates Leadership Change and Strategic Financial Growth Amidst Fluid Overload Solutions,

Nuwellis, Inc.: Leadership Transition Amidst Financial Growth and Strategic Vision for the FutureIn a transformative period for Nuwellis, Inc. a key player in the medical technology industry, the company recently announced the retirement of Nestor Jaramillo, Jr. as President and CEO. In a corresponding move, John Erb, the current Chair of the Board, has been appointed as the Interim President and CEO, heralding a new chapter in the company s leadership.Jaramillo leaves behind a legacy that has significantly shaped Nuwellis’s trajectory in developing solutions for fluid overload in patients—an area where the need for innovative medical technology has never been more critical. His tenure was marked by a commitment to creating breakthrough therapies, customer-centric solutions, and navigating the complexities of the healthcare landscape.




Other Ratios
Nuwellis Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NUWE's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NUWE's Competitors
Revenue per Employee for NUWE's Suppliers
Revenue per Employee for NUWE's Customers

You may also want to know
NUWE's Sales Growth Rates NUWE's Pe Price to earnings ratio NUWE's Receivables Turnover Ratio NUWE's Stock Quote
NUWE's Net Income Growth Rates NUWE's Ps Price to Sales ratio NUWE's Sales per Employee NUWE's Asset Turnover Ratio
NUWE's Net Margin NUWE's Pb Price to Book ratio NUWE's Financial Strength Ratios NUWE's Dividend Payout Ratio
Date modified: 2026-09-03T12:04:35+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Tandem Diabetes Care Inc   414,920.80 $ 1,037.302  Million 2,500 
Idexx Laboratories Inc  413,981.09 $ 4,553.792  Million 11,000 
Talkspace Inc   412,426.42 $ 246.631  Million 598 
Adc Therapeutics Sa  412,352.33 $ 79.584  Million 193 
Quidelortho Corp  411,415.38 $ 2,674.200  Million 6,500 
Bausch and Lomb Corp  409,538.46 $ 5,324.000  Million 13,000 
Immucell Corporation  407,900.08 $ 29.777  Million 73 
Agilent Technologies inc   407,292.82 $ 7,372.000  Million 18,100 
Edwards Lifesciences Corporation  407,031.25 $ 6,512.500  Million 16,000 
Sotera Health Company  405,308.33 $ 1,215.925  Million 3,000 
Vanda Pharmaceuticals Inc   404,729.83 $ 215.721  Million 533 
Bio techne Corp  404,623.00 $ 1,213.869  Million 3,000 
Castle Biosciences Inc   404,618.35 $ 357.278  Million 883 
Axogen inc   403,816.72 $ 251.174  Million 622 
Xencor Inc  403,742.31 $ 104.973  Million 260 
Lensar Inc   401,760.00 $ 60.264  Million 150 
Lemaitre Vascular Inc   401,409.16 $ 262.923  Million 655 
Verrica Pharmaceuticals Inc   398,960.53 $ 30.321  Million 76 
Yunhong Green Cti Ltd   397,346.15 $ 20.662  Million 52 
Innovage Holding Corp   395,882.80 $ 989.707  Million 2,500 
Medtronic Plc  395,178.95 $ 37,542.000  Million 95,000 
Repligen Corp  392,550.50 $ 785.101  Million 2,000 
Nrc Health  392,145.66 $ 139.996  Million 357 
Aligos Therapeutics Inc   384,365.85 $ 31.518  Million 82 
Edap Tms Sa  384,259.52 $ 111.051  Million 289 
Precipio inc   383,070.42 $ 27.198  Million 71 
Logicmark Inc  380,123.06 $ 12.544  Million 33 
Procept Biorobotics Corporation  379,238.74 $ 336.764  Million 888 
Outset Medical Inc   379,196.77 $ 117.551  Million 310 
Pro dex Inc   376,446.60 $ 77.548  Million 206 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.